SCHEMBL4955539

SCHEMBL4955539

Nn1cnc2cc(O)c(O)cc21

nearest known ligand 0.59

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.50
SRC P12931 2/20 0.50
PLAA Q9Y263 2/20 0.32
ALPG P10696 2/20 0.31
MAPT P10636 1/20 0.31
HSD17B10 Q99714 1/20 0.31
ALPL P05186 1/20 0.30
ALPI P09923 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4951994 0.76 FGFR1 (0.52) FGFR1SRCPLAAALPGALPL
Bromide SCHEMBL11361032 0.72 FGFR1 (0.49) FGFR1SRCMAPTHSD17B10
SCHEMBL12464366 0.69 HCAR3 (0.53) FGFR1SRCPLAAMAPTHSD17B10
SCHEMBL2269527 0.69 FGFR1 (0.46) FGFR1SRCPLAAALPGMAPT
SCHEMBL4955132 0.69 FGFR1 (0.46) FGFR1SRCPLAAALPGMAPT
SCHEMBL19911410 0.68 MAPT (0.58) FGFR1MAPTHSD17B10
SCHEMBL7993203 0.67 FGFR1 (1.00) FGFR1SRC
SCHEMBL19848148 0.67 BACE1 (0.37)
SCHEMBL15241833 0.67 FGFR1 (0.54) FGFR1MAPTHSD17B10
SCHEMBL19848508 0.67 GFER (0.36) FGFR1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371264-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-05-13 US claimed
US-20060042026-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2006-03-02 US claimed
US-7371264-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-05-13 US disclosed
EP-1781379-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2007-05-09 EP disclosed
WO-2006026495-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2006-03-09 WO disclosed
US-20060042026-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060042026-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, KDM5A, KDM5C FGFR1 3538/4885SRC 2096/4885PLAA 4228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.